Company profile: PathologyWatch
1.1 - Company Overview
Company description
- Provider of an intuitive, easy-to-implement digital pathology solution for dermatologists, partnering with clinical dermatology practices to digitize the pathology workflow to improve patient care, reduce costs, and open new potential revenue streams for clinics and hospitals.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to PathologyWatch
Breezie
HQ: United Kingdom
Website
- Description: Provider of personalized, intuitive software that simplifies Android tablets for people less familiar with digital technology by removing clutter and jargon from popular apps and services, and VitalCare solutions for virtual care coordination, real-time patient monitoring and alerts, family engagement, analytics and outcome visualization, chronic care management, and remote monitoring for chronic kidney disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Breezie company profile →
LeanTaaS
HQ: United States
Website
- Description: Provider of the iQueue platform using advanced data science to improve hospital and clinic operations. Offerings include iQueue for Operating Rooms (AI-driven scheduling, utilization, and block management), iQueue for Infusion Centers (predictive scheduling and capacity), iQueue for Inpatient Flow (bed and flow optimization), and Transformation as a Service.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LeanTaaS company profile →
iCAD
HQ: United States
Website
- Description: Provider of cancer detection and therapy solutions, offering breast health software for digital breast tomosynthesis and breast density, and tools to support breast cancer detection and analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full iCAD company profile →
SafeRide Health
HQ: United States
Website
- Description: Provider of a healthcare technology platform for non-emergency medical transportation, offering NEMT management, customizable solutions for health plans, real-time ride visibility, data-driven insights, fleet management tools for transportation providers, and member-centric ride booking via call center or online to enhance access to care and coordination.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SafeRide Health company profile →
WuXi Diagnostics
HQ: China
Website
- Description: Provider of integrated diagnosis solutions and comprehensive clinical testing services, including a diagnostic decision-making package integrating clinical technology, diagnostic pathways, algorithms and medical content for early screening, precise diagnosis, decision support and prognosis management; clinical mass spectrometry; molecular and next-generation sequencing; pathology diagnosis; biochemical immunology; and independent medical lab services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full WuXi Diagnostics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for PathologyWatch
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to PathologyWatch
2.2 - Growth funds investing in similar companies to PathologyWatch
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for PathologyWatch
4.2 - Public trading comparable groups for PathologyWatch
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →